Protection Against N-methyl-D-aspartate Receptor-Mediated Neuronal Degeneration In Rat Brain by 7-chlorokynurenate and 3-amino-1-hydroxypyrrolid-2-one, Antagonists at The Allosteric Site for Glycine - PubMed (original) (raw)
Protection Against N-methyl-D-aspartate Receptor-Mediated Neuronal Degeneration In Rat Brain by 7-chlorokynurenate and 3-amino-1-hydroxypyrrolid-2-one, Antagonists at The Allosteric Site for Glycine
A. C. Foster et al. Eur J Neurosci. 1990.
Abstract
7-Chlorokynurenate (7-Cl KYNA) and 3-amino-1-hydroxypyrrolid-2-one (HA-966), two selective antagonists of the glycine site on the N-methyl-D-aspartate (NMDA) receptor, have been used to assess the involvement of this site in the neurodegeneration resulting from injection of excitotoxins in the rat brain. In the rat striatum, reductions in the enzymes choline acetyltransferase (CAT) and glutamate decarboxylase (GAD), occurring 7 days after a unilateral, intrastriatal injection of quinolinate (200 nmol), were prevented in a dose-dependent manner by intrastriatal administration of 7-Cl KYNA (10 - 50 nmol) and HA-966 (200 - 500 nmol) 1 h after the excitotoxin. In the rat hippocampus, degeneration of pyramidal and granule neurons caused by direct injection of quinolinate (60 nmol) was completely prevented by 7-Cl KYNA (50 nmol) and partially by HA-966 (500 nmol) injected intrahippocampally 1 h after the excitotoxin. In the rat striatum, 7-Cl KYNA (50 nmol) and HA-966 (500 nmol) also reduced neurotoxicity caused by intrastriatal injection of NMDA (200 nmol), but not that caused by the 'non-NMDA' receptor agonists DL-alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate (AMPA) or kainate. The time course of protective effects of 7-Cl KYNA and HA-966 in the striatum was similar to that previously observed with the uncompetitive NMDA receptor antagonist MK-801, indicating that activation of the glycine site contributes to the delayed degeneration of neurons which occurs over the first 5 h following quinolinate injection. The neuroprotective effects of both 7-Cl KYNA and HA-966 in the rat striatum appear to be mediated via the glycine site on the NMDA receptor as they were completely reversed by D-serine, but not L-serine. These results indicate that activation of the glycine site is essential for the expression of the delayed degeneration of neurons resulting from intracerebral injection of an NMDA receptor agonist, a process which bears similarities to the delayed neurodegeneration which results from a period of cerebral ischaemia.
Similar articles
- Neuroprotective effects of MK-801 in vivo: selectivity and evidence for delayed degeneration mediated by NMDA receptor activation.
Foster AC, Gill R, Woodruff GN. Foster AC, et al. J Neurosci. 1988 Dec;8(12):4745-54. doi: 10.1523/JNEUROSCI.08-12-04745.1988. J Neurosci. 1988. PMID: 2904493 Free PMC article. - In situ produced 7-chlorokynurenate provides protection against quinolinate- and malonate-induced neurotoxicity in the rat striatum.
Guidetti P, Wu HQ, Schwarcz R. Guidetti P, et al. Exp Neurol. 2000 May;163(1):123-30. doi: 10.1006/exnr.1999.7284. Exp Neurol. 2000. PMID: 10785450 - Kynurenic acid analogues with improved affinity and selectivity for the glycine site on the N-methyl-D-aspartate receptor from rat brain.
Foster AC, Kemp JA, Leeson PD, Grimwood S, Donald AE, Marshall GR, Priestley T, Smith JD, Carling RW. Foster AC, et al. Mol Pharmacol. 1992 May;41(5):914-22. Mol Pharmacol. 1992. PMID: 1375317 - The Discovery and Characterization of Targeted Perikaryal-Specific Brain Lesions With Excitotoxins.
Coyle JT, Schwarcz R. Coyle JT, et al. Front Neurosci. 2020 Sep 8;14:927. doi: 10.3389/fnins.2020.00927. eCollection 2020. Front Neurosci. 2020. PMID: 33013307 Free PMC article. Review.
Cited by
- Anxiolytic effect of glycine antagonists microinjected into the dorsal periaqueductal grey.
Matheus MG, Nogueira RL, Carobrez AP, Graeff FG, Guimarães FS. Matheus MG, et al. Psychopharmacology (Berl). 1994 Jan;113(3-4):565-9. doi: 10.1007/BF02245241. Psychopharmacology (Berl). 1994. PMID: 7862877 - Kynurenine pathway metabolites in humans: disease and healthy States.
Chen Y, Guillemin GJ. Chen Y, et al. Int J Tryptophan Res. 2009;2:1-19. doi: 10.4137/ijtr.s2097. Epub 2009 Jan 8. Int J Tryptophan Res. 2009. PMID: 22084578 Free PMC article. - Pharmacological therapy in Parkinson's disease: focus on neuroprotection.
Kincses ZT, Vecsei L. Kincses ZT, et al. CNS Neurosci Ther. 2011 Oct;17(5):345-67. doi: 10.1111/j.1755-5949.2010.00150.x. Epub 2010 Apr 23. CNS Neurosci Ther. 2011. PMID: 20438581 Free PMC article. Review. - A behavioral model of excitotoxicity: retinal degeneration, loss of vision, and subsequent recovery after intraocular NMDA administration in adult rats.
Sabel BA, Sautter J, Stoehr T, Siliprandi R. Sabel BA, et al. Exp Brain Res. 1995;106(1):93-105. doi: 10.1007/BF00241359. Exp Brain Res. 1995. PMID: 8542981 - Natural Molecules and Neuroprotection: Kynurenic Acid, Pantethine and α-Lipoic Acid.
Tóth F, Cseh EK, Vécsei L. Tóth F, et al. Int J Mol Sci. 2021 Jan 2;22(1):403. doi: 10.3390/ijms22010403. Int J Mol Sci. 2021. PMID: 33401674 Free PMC article. Review.
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous